Skip to main content

N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients

Abstract

The aim of this study was to find the relationship between N-terminal brain natriuretic propeptide (NT-proBNP), procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations in septic patients. This was a prospective study, performed at Medical University Hospital No. 5 in łódź. Twenty patients with sepsis and severe sepsis were included in the study. N-terminal brain natriuretic propeptide, procalcitonin and C-reactive protein concentrations, and survival were evaluated. In the whole studied group (128 measurements), the mean NT-proBNP, procalcitonin and C-reactive protein concentrations were, respectively: 140.80±84.65 pg/ml, 22.32±97.41 ng/ml, 128.51±79.05 mg/l. The correlations for the NT-proBNP level and procalcitonin and C-reactive protein levels were 0.3273 (p<0.001) and 0.4134 (p<0.001), respectively. NT-proBNP levels correlate with PCT and CRP levels in septic patients. In the survivor subgroup, the mean NT-proBNP plasma concentrations were significantly lower than in the non-survivor subgroup.

Abbreviations

ACCP/SCCM:

American College of Chest Physicians/Society of Critical Care Medicine

APACHE II score:

acute physiological and chronic health evaluation ii score

BNP:

brain natriuretic peptide

CRP:

C-reactive protein

NT-proBNP:

N-terminal brain natriuretic propeptide

PCT:

procalcitonin

SIRS:

systemic inflammatory response syndrome

SOFA score:

sepsis-related organ failure assessment score

References

  1. Members of the American College of Chest Physicians/ Society of Crit Care Med Consensus Conference Committee: American College of Chest Physicians/Society of Crit Care Med Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20 (1992) 864–874.

    Article  Google Scholar 

  2. Ugarte, H., Silva, E., Mercan, D., De Mendonca, A. and Vincent J.L. Procalcitonin as a marker of infection in the intensive care unit. Crit. Care Med. 27 (1999) 498–504.

    Article  CAS  Google Scholar 

  3. Wanner, G.A., Keel, M., Steckholzer, U., Beier, W., Stocker, R. and Ertel, W. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit. Care Med. 28 (2000) 950–957.

    Article  CAS  PubMed  Google Scholar 

  4. Hoffmann, U., Brueckmann, M., Bertsch, T., Wiessner, M., Liebetrau, C., Lang, S., Haase, K.K., Borggrefe, M. and Huhle, G. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin. Lab. 51 (2005) 373–379.

    CAS  PubMed  Google Scholar 

  5. Castillo, J.R., Zagler, A., Carrillo-Jimenez, R. and Hennekens, C.H. Brain natriuretic peptide: a potential marker for mortality in septic shock. Int. J. Infect. Dis. 8 (2004) 271–274.

    Article  CAS  PubMed  Google Scholar 

  6. Charpentier, J., Luyt, C.E., Fulla, Y., Vinsonneau, C., Cariou, A., Grabar, S., Dhainaut, J.F., Mira, J.P. and Chiche, J.D. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit. Care Med. 32 (2004) 660–665.

    Article  CAS  PubMed  Google Scholar 

  7. Witthaut, R., Busch, C., Fraunberger, P., Walli, A., Seidel, D., Pilz, G., Stuttmann, R., Speichermann, N., Verner, L. and Werdan, K. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 29 (2003) 1696–1702.

    Article  PubMed  Google Scholar 

  8. Nijsten, M.W., Olinga, P., The, T.H., de Vries, E.G., Koops, H.S., Groothuis, G.M., Limburg, P.C., Duis, H.J., Moshage, H., Hoekstra, H.J., Bijzet, J. and Zwaveling, J.H. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit. Care Med. 28 (2000) 586–588.

    Article  Google Scholar 

  9. Bohuon, C. A brief history of PCT. Intensive Care Med. 26 (2000) 146–147.

    Article  Google Scholar 

  10. Oberhoffer, M., Vogelsang, H., Jager, L. and Reinhart, K. Katacalcin and calcitonin immunoreactivity in different types of leukocytes. J. Crit. Care 14 (1999) 29–33.

    Article  CAS  PubMed  Google Scholar 

  11. Gramm, H.J., Beier, W., Zimmermann, J., Oedra, N., Hannemann, L. and Boese-Ladgraf, J. Procalcitonin-A biological marker of inflammatory response with prognostic properties. Clin. Intens. Care 6 (1995) 71.

    Google Scholar 

  12. Zeni, F., Viallon, A., Assicot, M., Tardy, B., Vindimian, M. and Page, Y. Procalcitonin serum concentrations and severity of sepsis. Clin. Intens. Care 5 (1994) 89–98.

    Google Scholar 

  13. Hergert, M., Lestin, H.G., Scherkus, M., Brikner, K., Klett, I. and Stranz, G. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 44 (1998) 659–670.

    CAS  Google Scholar 

  14. Oberhoffer, M., Biterlich, A., Hentschel, T., Meier-Hellmann, A., Vogelsang, H. and Reinhart, K. Procalcitonin (ProCT) correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response. Clin. Intens. Care 7 (1996) 46.

    Google Scholar 

  15. Oberhoffer, M., Vogelsang, H., Rasswurm, S., Hartung, T. and Reinhart, K. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin. Chem. Lab. Med. 37 (1999) 363–368.

    Article  CAS  PubMed  Google Scholar 

  16. Markuszewski, L., Rysz, J., Makowski, M., Debska, A. and Pietruszynski, R. C-reactive protein as a predictor of major adverse cardiac events (MACE) after percutaneous coronary intervention? Arch. Med. Sci. 1 (2005) 152–156.

    CAS  Google Scholar 

  17. Povoa, P., Almeida, E., Moreira, P., Fernandes, A., Mealha, R., Aragao, A. and Sabino, H. C-reactive protein as an indicator of sepsis. Intensive Care Med. 24 (1998) 1052–1056.

    Article  CAS  PubMed  Google Scholar 

  18. Brueckmann, M., Huhle, G., Lang, S., Haase, K.K., Bertsch, T., Weiss, C., Kaden, J.J., Putensen, C., Borggrefe, M. and Hoffmann, U. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112 (2005) 527–34

    Article  CAS  PubMed  Google Scholar 

  19. Chua, G. and Kang-Hoe, L. Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit. Care 8 (2004) 248–250.

    Article  Google Scholar 

  20. Piechota, M., Irzmanski, R., Banach, M., Barylski, M., Ostrowski, S., Kowalski, J. and Pawlicki, L. Can impedance cardiography be routinely applied in patients with sepsis and severe sepsis? Arch. Med. Sci. 2 (2006) 114–121.

    Google Scholar 

  21. Pinilla, J.C., Hayes, P., Laverty, W., Arnold, C. and Laxdal, V. The Creactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 124 (1998) 799–805.

    Article  CAS  PubMed  Google Scholar 

  22. Waydhas, C., Nast-Kolb, D., Trupka, A., Zettl, R., Kick, M., Wiesholler, J., Schweiberer, L. and Jochum, M. Post-traumatic inflammatory response, secondary operations, and late multiple organ failure. J. Trauma 40 (1996) 624–630.

    CAS  PubMed  Google Scholar 

  23. Rau, B., Steinbach, G., Baumgart, K., Gansauge, F., Grunert, A. and Beger, H.G. Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acute-phase reactant. Crit. Care Med. 28 (2000) 736–742.

    Article  CAS  PubMed  Google Scholar 

  24. Castelli, G.P., Pognani, C., Meisner, M., Stuani, A., Bellomi, D. and Sgarbi, L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit. Care Med. 8 (2004) 234–242.

    Article  Google Scholar 

  25. Tugrul, S., Esen, F., Celebi, S., Ozcan, P.E., Akinci, O., Cakar, N. and Telci, L. Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response. Anaesth. Intensive Care 30 (2002) 747–754.

    CAS  PubMed  Google Scholar 

  26. Hergert, M., Lestin, H.G., Scherkus, M., Brikner, K., Klett, I. and Stranz, G. Procalcitonin in patients with sepsis and polytrauma. Clin. Lab. 44 (1998) 659–670.

    CAS  Google Scholar 

  27. Piechota, M., Banach, M., Irzmanski, R., Barylski, M., Piechota-Urbanska, M., Kowalski, J., Pawlicki, L. Plasma endothelin-1 levels in septic patients. J. Intensive Care Med. 22 (2007), in press.

  28. Pereira-Barretto, A.C., de Oliveira, M.T., Franco, F.G. and Cassaro-Strunz, C. ProBNP for stratifying patients with heart failure. Arq. Bras. Cardiol. 81 (2003) 239–248.

    Article  PubMed  Google Scholar 

  29. Mueller, T., Gegenhuber, A., Poelz, W. and Haltmayer, M. Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NTproBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease. Clin. Chem. 49 (2003) 976–979.

    Article  PubMed  Google Scholar 

  30. Banach, M., Drozdz, J., Okonski, P. and Rysz, J. Immunological aspects of the statins’ function in patients with heart failure. The raport from the Annual Conference of ESC-Heart Failure 2005. Cell. Mol. Immunol. 2 (2005) 433–437.

    PubMed  Google Scholar 

  31. Prontera, C., Emdin, M., Zucchelli, G.C., Ripoli, A., Passino, C. and Clerico, A. Analytical performance and diagnostic accuracy of a fullyautomated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Clin. Chem. Lab. Med. 42 (2004) 37–44.

    Article  CAS  PubMed  Google Scholar 

  32. Dahlstrom, U. Can natriuretic peptides be used for the diagnosis of diastolic heart failure? Eur. J. Heart Fail. 6 (2004) 281–287.

    Article  CAS  PubMed  Google Scholar 

  33. Irzmanski, R., Banach, M., Piechota, M., Kowalski, J., Barylski, M., Cierniewski, C.S. and Pawlicki, L. Atrial, Brain Natriuretic Peptide and Endothelin-1 concentration in patients with idiopathic arterial hypertension. The dependence on the selected morphological parameters. Clin. Exp. Hypertens. 29 (2007), in press.

  34. Phua, J., Lim, T.K. and Lee, K.H. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit. Care Med. 33 (2005) 2094–2113.

    Article  PubMed  Google Scholar 

  35. Ma, K.K., Ogawa, T. and de Bold, A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by proinflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J. Mol. Cell. Cardiol. 36 (2004) 505–513.

    Article  CAS  PubMed  Google Scholar 

  36. Piechota, M., Irzmanski, R., Banach, M., Kowalski, J. and Pawlicki, L. Impedance cardiography in hemodynamic monitoring of septic patients: prospective study. Arch. Med. Sci. 3 (2007), in press.

  37. Banach, M. The role of immunological factors in the induction of apoptosis of cardiomyocytes. Drug Pol. 13 (2003) 50–56.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maciej Banach.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Piechota, M., Banach, M., Irzmański, R. et al. N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients. Cell Mol Biol Lett 12, 162–175 (2007). https://doi.org/10.2478/s11658-006-0062-y

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s11658-006-0062-y

Key words

  • N-terminal brain natriuretic propeptide
  • Procalcitonin
  • C-reactive protein
  • Sepsis
  • Severe sepsis